Supernus Pharmaceuticals reported $164.09M in Trade Debtors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Aerie Pharmaceuticals AERI:US USD 73.88M 5.8M
Ani Pharmaceuticals ANIP:US USD 144.21M 8.21M
Aurora Cannabis Inc ACB:CN CAD 45.94M 1.11M
Bristol Myers Squibb BMY:US USD 13.24B 700M
Canopy Growth Corp WEED:CN CAD 108.24M 11.61M
Cara Therapeutics CARA:US USD 10.77M 1.6M
Corcept Therapeutics CORT:US USD 29.41M 1.25M
Eisai 4523:JP JPY 178.09B 20.85B
Eli Lilly And LLY:US USD 8.32B 652.4M
Endo International Ordinary Shares ENDP:US USD 425.95M 75.15M
Horizon Pharma HZNP:US USD 646.39M 26.92M
Lannett LCI:US USD 74.43M 18.6M
Marinus Pharmaceuticals MRNS:US USD 3.4M 398K
Pacira Pharmaceuticals PCRX:US USD 93.47M 2.37M
Perrigo Ordinary Shares PRGO:US USD 739.5M 37.6M
Revance Therapeutics RVNC:US USD 11.73M 6.14M
Supernus Pharmaceuticals SUPN:US USD 164.09M 6.02M
Teva Pharmaceutical Industries TEVA:US USD 3.73B 741M
United Therapeutics UTHR:US USD 231.7M 58.3M
Xeris Pharmaceuticals Inc XERS:US USD 27.52M 1.76M